|
COLLABORATIONS
Nanobiomolecules is currently in negotiations with several companies interested in licensing the rP-nano™ technology. Companies keen to evaluate this technology include:
- major pharmaceutical companies
- biotech companies
- diagnostics companies
- consumer product / skin care companies
Typically, licensing negotiations are preceded by an evaluation agreement where Nanobiomolecules generates nanoparticle samples involving proprietary compounds from interested parties for further study. Alternatively, Nanobiomolecules can offer research licences and technology transfer services such that potential partners can generate nanobiomolecules in their own facilities.
|
